Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Sandercock

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Scottish Medical Journal|June 1, 1993
Recent developments in secondary prevention of strokeP A Sandercock
Scottish Medical Journal|April 1, 1990
Benign intracranial hypertension associated with danazolJ Pears, P A Sandercock
Scottish Medical Journal|October 1, 1990
Migraine or amaurosis fugax? The value of ultrasoundP A Sandercock, S E Smart
Drugs & Aging|August 25, 1999
Aspirin and heparin in acute ischaemic stroke in older patientsG J Gubitz, P A Sandercock
Stroke|December 1, 1990
Preventing stroke by the modification of risk factorsD W Dunbabin, P A Sandercock
Postgraduate Medical Journal|March 1, 1991
Investigation of acute stroke: what is the most effective strategy?D W Dunbabin, P A Sandercock
Postgraduate Medical Journal|January 1, 1992
Why test antiplatelet therapy in acute ischaemic stroke and how can this be done?R I Lindley, P A Sandercock
BMJ (Clinical Research Ed.)|May 17, 1997
Informed consent in medical research. Failure to publish completed randomised controlled trials is unethical in itselfC E Counsell, P A Sandercock
BMJ (Clinical Research Ed.)|May 22, 1993
Uses of heparin. Withhold in acute ischaemic strokeR I Lindley, P A Sandercock
Stroke|September 1, 1996
Considerations in the design of clinical trials of neuroprotective therapy in acute strokeP J Dorman, P A Sandercock
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Scottish Medical Journal|June 1, 1993
Recent developments in secondary prevention of strokeP A Sandercock
Scottish Medical Journal|April 1, 1990
Benign intracranial hypertension associated with danazolJ Pears, P A Sandercock
Scottish Medical Journal|October 1, 1990
Migraine or amaurosis fugax? The value of ultrasoundP A Sandercock, S E Smart
Drugs & Aging|August 25, 1999
Aspirin and heparin in acute ischaemic stroke in older patientsG J Gubitz, P A Sandercock
Stroke|December 1, 1990
Preventing stroke by the modification of risk factorsD W Dunbabin, P A Sandercock
Postgraduate Medical Journal|March 1, 1991
Investigation of acute stroke: what is the most effective strategy?D W Dunbabin, P A Sandercock
Postgraduate Medical Journal|January 1, 1992
Why test antiplatelet therapy in acute ischaemic stroke and how can this be done?R I Lindley, P A Sandercock
BMJ (Clinical Research Ed.)|May 17, 1997
Informed consent in medical research. Failure to publish completed randomised controlled trials is unethical in itselfC E Counsell, P A Sandercock
BMJ (Clinical Research Ed.)|May 22, 1993
Uses of heparin. Withhold in acute ischaemic strokeR I Lindley, P A Sandercock
Stroke|September 1, 1996
Considerations in the design of clinical trials of neuroprotective therapy in acute strokeP J Dorman, P A Sandercock
Pageof 5